About the Authors

Alexis-Pierre Bemelmans, Corinne Kostic, Sylvain V Crippa, Yvan Arsenijevic
Unit of Gene Therapy and Stem Cell Biology, Jules Gonin Eye Hospital, Lausanne, Switzerland

William W Hauswirth
Department of Ophthalmology, University of Florida, Gainesville, Florida, United States of America

Janis Lem
Department of Ophthalmology, Program in Genetics and Tufts Center for Vision Research, Tufts University School of Medicine, Boston, Massachusetts, United States of America

Francis L Munier
Unit of Clinical Oculogenetics, Jules Gonin Eye Hospital, Lausanne, Switzerland

Mathias W Seeliger
Retinal Electrodiagnostics Research Group, Department of Ophthalmology II, Eberhard-Karls University, Tübingen, Germany

Andreas Wenzel
Laboratory of Retinal Cell Biology, University Hospital, Zürich, Switzerland

Corresponding Author

yvan.arsenijevic@ophtal.vd.ch

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

APB, CK, AW, and YA designed the study. APB, CK, SVC, FLM, MWS, AW, and YA analyzed the data. APB, CK, FLM, AW, and YA contributed to writing the paper. WWH provided the R0.8 promoter used. JL created the Gnat1−/− transgenic mouse models used in the study.